The U.S. gastroenterology-facing ASC market will hit $10.8 billion by 2026, according to a Grand View Research market report.
What you should know:
1. The market was valued at $6.9 billion in 2018 and is projected to grow at a 5.91 percent compound annual growth rate from that time.
2. Analysts attributed the growth to cost efficiency, improved patient outcomes, disease prevalence, a growing geriatric population and the convenience of ASCs.
3. Analysts also said the industrywide shift to outpatient settings was a reason the market has been so attractive. The U.S. has approximately 9,280 ASCs, with the highest concentrations in California, Florida and Texas.